Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biogen
Content Channel
Biogen investigated by Italian regulator on ‘market abuse’ claims
Italy’s antitrust agency is investigating Biogen over claims it is abusing its market position regarding a test for MS drug Tysabri.
Ben Adams
May 27, 2026 7:38am
Eisai's push toward blockbuster Leqembi sales gains steam
May 15, 2026 11:35am
Merck, Zai Lab, Kailera-Hengrui—Fierce Pharma Asia
Apr 24, 2026 8:22am
Biogen bullish on America with Durham Bulls team up
Apr 20, 2026 8:50am
More transparency, evidence needed for accelerated nods: ICER
Apr 17, 2026 11:22am
With trial looming, Biogen and investors settle Aduhelm claims
Apr 8, 2026 11:28am
